PURE Bioscience, Inc.
Income Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|
| Revenue | $1.8M | $1.3M | $729.0K | $550.0K | $820.0K | $812.0K | $464.0K |
| Cost of Revenue | $760.0K | $441.0K | $285.0K | $344.0K | $565.0K | $264.0K | $131.0K |
| Gross Profit | $1.1M | $848.0K | $444.0K | $206.0K | $255.0K | $548.0K | $333.0K |
| Gross Margin | 58.5% | 65.8% | 60.9% | 37.5% | 31.1% | 67.5% | 71.8% |
| Operating Expenses | |||||||
| Research & Development | $779.0K | $927.0K | $790.0K | $1.0M | $1.2M | $1.9M | $2.2M |
| SG&A Expense | $5.2M | $5.1M | $4.9M | $5.1M | $5.2M | $7.4M | $6.5M |
| Operating Income | $-6.0M | $-7.1M | $-7.6M | $-11.9M | $-7.3M | $-8.8M | $-8.4M |
| Operating Margin | -328.1% | -547.5% | -1,048.0% | -2,164.0% | -895.0% | -1,078.1% | -1,803.2% |
| Interest Expense | — | — | $8.0K | $10.0K | $593.0K | $144.0K | $0 |
| Pretax Income | — | — | — | — | — | — | — |
| Income Tax Expense | $1.7K | $1.6K | $1.6K | — | — | — | — |
| Net Income | $-6.3M | $-14.4M | $-7.6M | $-11.1M | $-7.7M | $-8.9M | $-8.3M |
| Net Margin | -342.1% | -1,114.9% | -1,046.2% | -2,009.1% | -935.5% | -1,094.8% | -1,799.4% |
| EPS (Basic) | $-0.10 | $-0.25 | $-0.19 | $-0.43 | $-0.71 | $-1.58 | $-1.79 |
| EPS (Diluted) | $-0.10 | $-0.25 | $-0.19 | $-0.43 | $-0.71 | $-1.58 | $-1.79 |
| Shares Outstanding (Basic) | 67.9M | 64.8M | 55.2M | 39.8M | 23.4M | 11.0M | — |
| Shares Outstanding (Diluted) | 67.9M | 64.8M | 55.2M | 39.8M | 23.4M | 11.0M | — |
| Dividends Per Share | — | — | — | — | — | — | — |